Literature DB >> 16358561

Stevioside is a novel stimulator of pharmacon clathration with glycosides.

T G Tolstikova1, A O Bryzgalov, I V Sorokina, E A Morozova, S E Tolstikov, A V Al'fonsov, A G Tolstikov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16358561     DOI： 10.1007/s10630-005-0100-3

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN： 0012-4966


× No keyword cloud information.
  4 in total

1.  Inhibitory effect of stevioside on calcium influx to produce antihypertension.

Authors:  C N Lee; K L Wong; J C Liu; Y J Chen; J T Cheng; P Chan
Journal:  Planta Med       Date:  2001-12       Impact factor: 3.352

2.  Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo: studies in the diabetic Goto-Kakizaki (GK) rats.

Authors:  P B Jeppesen; S Gregersen; K K Alstrup; K Hermansen
Journal:  Phytomedicine       Date:  2002-01       Impact factor: 5.340

Review 3.  Stevioside.

Authors:  Jan M C Geuns
Journal:  Phytochemistry       Date:  2003-11       Impact factor: 4.072

4.  The effect of stevioside on blood pressure and plasma catecholamines in spontaneously hypertensive rats.

Authors:  P Chan; D Y Xu; J C Liu; Y J Chen; B Tomlinson; W P Huang; J T Cheng
Journal:  Life Sci       Date:  1998       Impact factor: 5.037
  4 in total
  4 in total

1.  To the nature of the effect of glycosidic clathration of pharmacons.

Authors:  T G Tolstikova; A O Bryzgalov; I V Sorokina; A S Ratushnyak; T A Zapara; O G Simonova; G A Tolstikov
Journal:  Dokl Biol Sci       Date:  2007 Sep-Oct

2.  Rebaudioside, a novel agent of glycoside clathration of pharmacons.

Authors:  T G Tolstikova; A O Bryzgalov; M V Khvostov; G A Tolstikov
Journal:  Dokl Biol Sci       Date:  2009 May-Jun

3.  Formation of salts with hydrobromic acid determines the antiarrhythmic effect of lappaconitine derivatives.

Authors:  T G Tolstikova; A O Bryzgalov; I V Sorokina; M P Dolgikh; E E Shul'ts; S A Osadchii; G A Tolstikov
Journal:  Dokl Biol Sci       Date:  2007 Jul-Aug

4.  On the way to low-dose medicines.

Authors:  T G Tolstikova; A G Tolstikov; G A Tolstikov
Journal:  Her Russ Acad Sci       Date:  2007       Impact factor: 0.560
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.